Literature DB >> 2424747

Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes.

J F McLeod, M A Kowalski, J G Haddad.   

Abstract

We have developed a murine hybridoma cell line that secretes a monoclonal antibody directed to the serum human vitamin D binding protein (hDBP), a 58,000-dalton alpha-globulin with a high avidity for 25-hydroxycholecalciferol and globular actin. This immunoglobulin G1 kappa-light chain antibody was produced by the fusion of the spleen cells from BALB/c mice, immunized with purified hDBP, with SP2/0-AG4 myeloma cells. The antibody was easily removed from the supernatant of hybridoma cultures or mouse ascites fluid by Protein A affinity chromatography. Apparent serum monospecificity was demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and isoelectric focusing gels transblotted to nylon membranes and overlayed with purified MAK 89 antibody and radioiodinated Protein A. The affinity of the antibody is high [dissociation constant (Kd) = 2.6 X 10(-11) M]. Parallel displacement of tracer by hDBP and human serum was observed. The sera from various species displaced the hDBP tracer in the following potency: monkey more than cat more than dog more than guinea pig. RIAs for DBP from several species are feasible with this antibody. This antibody does not, in contrast to polyclonal anti-hDBP antiserum, bind to viable monocytes. However, the MAK 89 antibody does bind to the membranes of well washed, fixed, and permeant circulating monocytes. Surface membrane radioiodination of monocytes and immunoprecipitation of the detergent lysates with the antibody demonstrates a protein with molecular weight equivalent to hDBP. The epitope recognized, therefore, appears to be hidden in the viable cells, suggesting an intimate and intricate association of the hDBP and monocyte plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424747     DOI: 10.1210/endo-119-1-77

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein.

Authors:  M Petrini; A Allegrini; F Ambrogi; P Valentini; A Sabbatini; P Arnaud; R M Galbraith
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit.

Authors:  P J Goldschmidt-Clermont; H Van Baelen; R Bouillon; T E Shook; M H Williams; A E Nel; R M Galbraith
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Identification of two distinct cell binding sequences in the vitamin D binding protein.

Authors:  Jianhua Zhang; David M Habiel; Mahalakshmi Ramadass; Richard R Kew
Journal:  Biochim Biophys Acta       Date:  2010-03-06

4.  A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc).

Authors:  R Hoffmann; A Braun; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

5.  Vitamin D binding protein sequesters monomeric actin in the circulation of the rat.

Authors:  K D Harper; J F McLeod; M A Kowalski; J G Haddad
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Placental Vitamin D-Binding Protein Expression in Human Idiopathic Fetal Growth Restriction.

Authors:  Alice F Wookey; Tejasvy Chollangi; Hannah E J Yong; Bill Kalionis; Shaun P Brennecke; Padma Murthi; Harry M Georgiou
Journal:  J Pregnancy       Date:  2017-02-15

7.  Reduction in circulating vitamin D binding protein in patients with multiple sclerosis.

Authors:  Zhila Maghbooli; Abolfazl Omidifar; Tarlan Varzandi; Tayebeh Salehnezhad; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2021-04-20       Impact factor: 2.474

8.  Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses.

Authors:  Louisa E Jeffery; Alice M Wood; Omar S Qureshi; Tie Zheng Hou; David Gardner; Zoe Briggs; Satdip Kaur; Karim Raza; David M Sansom
Journal:  J Immunol       Date:  2012-10-19       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.